Find Itacitinib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1334298-90-6, Incb039110, Incb-039110, 2-(3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-1-(1-(3-fluoro-2-(trifluoromethyl)isonicotinoyl)piperidin-4-yl)azetidin-3-yl)acetonitrile, Incb39110, 19j3781lpm
Molecular Formula
C26H23F4N9O
Molecular Weight
553.5  g/mol
InChI Key
KTBSXLIQKWEBRB-UHFFFAOYSA-N
FDA UNII
19J3781LPM

Itacitinib
Itacitinib is an orally bioavailable inhibitor of Janus-associated kinase 1 (JAK1) with potential antineoplastic and immunomodulating activities. Upon oral administration, itacitinib selectively inhibits JAK-1, thereby inhibiting the phosphorylation of signal transducer and activator of transcription (STAT) proteins and the production of proinflammatory factors induced by other cytokines, including interleukin-23 (IL-23) and interleukin-6 (IL-6). The JAK-STAT pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; JAK kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies.
1 2D Structure

Itacitinib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[1-[1-[3-fluoro-2-(trifluoromethyl)pyridine-4-carbonyl]piperidin-4-yl]-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile
2.1.2 InChI
InChI=1S/C26H23F4N9O/c27-20-18(1-7-32-22(20)26(28,29)30)24(40)37-9-3-17(4-10-37)38-13-25(14-38,5-6-31)39-12-16(11-36-39)21-19-2-8-33-23(19)35-15-34-21/h1-2,7-8,11-12,15,17H,3-5,9-10,13-14H2,(H,33,34,35)
2.1.3 InChI Key
KTBSXLIQKWEBRB-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CN(CCC1N2CC(C2)(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)C(=O)C6=C(C(=NC=C6)C(F)(F)F)F
2.2 Other Identifiers
2.2.1 UNII
19J3781LPM
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (1-(1-(3-fluoro-2-(trifluoromethyl)isonicotinoyl)-4-piperidinyl)-3-(4-(1h-pyrrolo(2,3-d)pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-azetidinyl)acetonitrile

2.3.2 Depositor-Supplied Synonyms

1. 1334298-90-6

2. Incb039110

3. Incb-039110

4. 2-(3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-1-(1-(3-fluoro-2-(trifluoromethyl)isonicotinoyl)piperidin-4-yl)azetidin-3-yl)acetonitrile

5. Incb39110

6. 19j3781lpm

7. 2-[1-[1-[3-fluoro-2-(trifluoromethyl)pyridine-4-carbonyl]piperidin-4-yl]-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile

8. 3-azetidineacetonitrile, 1-(1-((3-fluoro-2-(trifluoromethyl)-4-pyridinyl)carbonyl)-4-piperidinyl)-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1h-pyrazol-1-yl)-

9. 1-[1-[[3-fluoro-2-(trifluoromethyl)-4-pyridinyl]carbonyl]-4-piperidinyl]-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]-3-azetidineacetonitrile

10. Itacitinib [usan]

11. Unii-19j3781lpm

12. 2-(3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1h-pyrazol-1-yl)-1-(1-(3-fluoro-2-(trifluoromethyl)isonicotinoyl)piperidin-4-yl)azetidin-3-yl)acetonitrile

13. Examlpe 294 [wo2011112662]

14. Itacitinib [inn]

15. Itacitinib (usan/inn)

16. Itacitinib [usan:inn]

17. Itacitinib [who-dd]

18. Itacitinib (incb39110)

19. Itacitinib(incb039110)

20. Itacitinib; Incb039110

21. Gtpl8364

22. Schembl2396080

23. Chembl3622820

24. C26h23f4n9o

25. Amy1814

26. Bdbm246868

27. Incb 39110

28. Incb-39110

29. Bcp13794

30. Ex-a1674

31. Nsc792849

32. Nsc796224

33. Nsc801001

34. S7812

35. Zinc118795962

36. At16231

37. Ccg-270017

38. Cs-5593

39. Db12154

40. Nsc-792849

41. Nsc-796224

42. Nsc-801001

43. Sb13363

44. {1-{1-[3-fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-yl}-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]azetidin-3-yl}acetonitrile

45. 1651228-00-0

46. 2-(1-{1-[3-fluoro-2-(trifluoromethyl)pyridine-4-carbonyl]piperidin-4-yl}-3-(4-{7h-pyrrolo[2,3-d]pyrimidin-4-yl}-1h-pyrazol-1-yl)azetidin-3-yl)acetonitrile

47. Ac-29031

48. As-75259

49. Hy-16997

50. A14390

51. D10944

52. Us10053465, 7

53. A902364

54. Q27891174

55. Incb039110;incb-039110;incb 039110

56. Incb39110;incb-39110;incb 39110; Incb039110; Incb-039110; Incb 039110

57. (1-(1-(3-fluoro-2-(trifluoromethyl)pyridine- 4-carbonyl)piperidin-4-yl)-3-(4-(7h-pyrrolo(2,3-d)pyrimidin- 4-yl)-1h-pyrazol-1-yl)azetidin-3-yl)acetonitrile

58. {1-{1-[3-fluoro-2- (trifluoromethyl) Isonicotinoyl] Piperidin-4- Yl}-3-[4-(7h- Pyrrolo[2,3- D]pyrimidin-4-yl)- 1h-pyrazol-1- Yl]azetidin-3- Yl}acetonitrile

59. 1-[1-[[3-fluoro-2-(trifluoromethyl)-4-pyridinyl]carbonyl]-4-piperidinyl]-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]-3-azetidineacetonitrile;itacitinib

60. 2-(3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-1-(1-(3-fluoro-2-(trifluoromethyl)-isonicotinoyl)piperidin-4-yl)azetidin-3-yl)acetonitrile

2.4 Create Date
2011-10-11
3 Chemical and Physical Properties
Molecular Weight 553.5 g/mol
Molecular Formula C26H23F4N9O
XLogP31.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count11
Rotatable Bond Count5
Exact Mass553.19616904 g/mol
Monoisotopic Mass553.19616904 g/mol
Topological Polar Surface Area120 Ų
Heavy Atom Count40
Formal Charge0
Complexity977
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of acute graft versus host disease


5 Pharmacology and Biochemistry
5.1 ATC Code

L - Antineoplastic and immunomodulating agents

L04 - Immunosuppressants

L04A - Immunosuppressants

L04AA - Selective immunosuppressants

L04AA46 - Itacitinib


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty